Novanta Inc. (FRA:1GSN)

Germany flag Germany · Delayed Price · Currency is EUR
123.00
-1.00 (-0.81%)
Last updated: Jul 28, 2026, 8:01 AM CET
Market Cap4.67B +20.5%
Revenue (ttm)871.99M +5.6%
Net Income46.61M -23.9%
EPS1.23 -27.6%
Shares Out n/a
PE Ratio100.26
Forward PE34.76
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Open123.00
Previous Close124.00
Day's Range123.00 - 123.00
52-Week Range84.50 - 145.00
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateAug 5, 2026

About Novanta

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment s... [Read more]

Industry Electronic Components, not elsewhere classified
Founded 1968
Employees 3,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 1GSN

Financial Performance

In 2025, Novanta's revenue was $980.60 million, an increase of 3.30% compared to the previous year's $949.25 million. Earnings were $53.83 million, a decrease of -16.01%.

Financial numbers in USD Financial Statements

News

Novanta completes acquisition of Riverpoint Medical

Novanta (NOVT) announced that it has completed the acquisition of Riverpoint Medical from Arlington Capital Partners. The transaction is expected to generate a high single-digit return on invested cap...

1 day ago - TheFly

Novanta Completes Acquisition of Riverpoint Medical

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today announced that it has ...

1 day ago - Business Wire

Novanta Inc. Announces Schedule of Second Quarter 2026 Earnings Release and Conference Call

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2026 resu...

13 days ago - Business Wire

Novanta registers to sell 2.14M common shares for holders

This filing relates to the offer and sale from time to time by the selling stockholders of up to 2.14M common shares. The company is not selling any shares under…

4 weeks ago - TheFly

Novanta to Present at the CJS Securities 26th Annual New Ideas Summer Conference on Thursday, July 9, 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chie...

5 weeks ago - Business Wire

Novanta Transcript: M&A announcement

The acquisition of Riverpoint Medical accelerates expansion into high-growth surgical consumables, is immediately accretive, and brings significant synergies and recurring revenue growth. The deal strengthens market position, leverages existing customer relationships, and sets a platform for future expansion.

7 weeks ago - Transcripts

Novanta Slides: M&A announcement

Novanta has posted slides in relation to its latest quarterly earnings report, which was published on June 9, 2026.

7 weeks ago - Filings

Novanta Press release: M&A announcement

Novanta issued a press release on June 9, 2026, disclosing material business information to investors.

7 weeks ago - Filings

Novanta price target raised to $180 from $173 at Baird

Baird analyst Quinn Fredrickson raised the firm’s price target on Novanta (NOVT) to $180 from $173 and keeps an Outperform rating on the shares.

7 weeks ago - TheFly

Novanta announces $300M private placement

Novanta (NOVT) announced that it has entered into a securities purchase agreement for a private placement of the company’s common shares to institutional and other accredited investors that is expecte...

7 weeks ago - TheFly

Novanta Inc. Announces $300 Million Private Placement

BOSTON--(BUSINESS WIRE)--Novanta Inc. ("Novanta" or the “Company”) announced today that it has entered into a securities purchase agreement for a private placement of the Company's common shares (“Com...

7 weeks ago - Business Wire

Novanta acquires Riverpoint Medical for $1.45B

Novanta (NOVT) has entered into a definitive agreement to acquire Riverpoint Medical, a company providing minimally invasive surgical consumables, from Arlington Capital, a Washington D.C.-area privat...

7 weeks ago - TheFly

Novanta Inc. Announces Acquisition of Riverpoint Medical

BOSTON--(BUSINESS WIRE)--Novanta Inc. (NASDAQ: NOVT) (“Novanta” or the “Company”), a trusted technology partner to leading global medical and industrial original equipment manufacturers (OEMs), today ...

7 weeks ago - Business Wire

Novanta Transcript: 46th Annual William Blair Growth Stock Conference

Portfolio now over 50% medical, with reduced semiconductor exposure and strong focus on robotics, automation, and recurring revenue. Growth driven by innovation in medical consumables, intelligent subsystems, and GenAI-linked technologies, with double-digit growth targeted through organic and M&A strategies.

7 weeks ago - Transcripts

Novanta Transcript: AGM 2026

The meeting covered board introductions, review of 2025 financials, and voting on director elections, executive compensation, and auditor appointment. All proposals passed, and no shareholder questions were raised.

2 months ago - Transcripts

Novanta Slides: Investor presentation

Novanta has posted slides in relation to its latest quarterly earnings report, which was published on May 26, 2026.

2 months ago - Filings

Novanta to Present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chie...

2 months ago - Business Wire

Novanta to Present at Baird 2026 Global Consumer, Technology & Services Conference on Wednesday, June 3, 2026

BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chie...

2 months ago - Business Wire

Novanta price target raised to $173 from $144 at Baird

Baird raised the firm’s price target on Novanta (NOVT) to $173 from $144 and keeps an Outperform rating on the shares. The firm updated its model following Q1 results showing…

2 months ago - TheFly

Novanta Earnings Call Transcript: Q1 2026

Q1 2026 saw double-digit bookings and revenue growth across all businesses, with strong cash flow and margin expansion despite tariff and cost headwinds. Guidance for 2026 was raised, supported by robust demand in AI, medical, and automation markets, and a strong acquisition pipeline.

2 months ago - Transcripts

Novanta Earnings release: Q1 2026

Novanta released its Q1 2026 earnings on May 12, 2026, summarizing the period's financial results.

2 months ago - Filings

Novanta Quarterly report: Q1 2026

Novanta has published its Q1 2026 quarterly earnings report on May 12, 2026.

2 months ago - Filings

Novanta reports Q1 adjusted EPS 81c, consensus 78c

Reports Q1 revenue $257.7M, consensus $253.4M. “Novanta (NOVT) delivered another quarter of excellent bookings, growing 37% year-over-year and representing a 1.10 book-to-bill ratio, driven by continu...

2 months ago - TheFly

Novanta sees Q2 adjusted EPS 81c-86c, consensus 86c

Sees Q2 revenue $259M-$264M, consensus $257.08M.

2 months ago - TheFly

Novanta backs FY26 adjusted EPS view $3.50-$3.65, consensus $3.56

Raises FY26 revenue view to $1.04B-$1.055B from $1.03B-$1.05B, consensus $1.04B.

2 months ago - TheFly